Immunologische Pathomechanismen bei Spättypallergie auf Betalactamantibiotika

Die Entwicklung von Allergien ist auf das komplexe Zusammenspiel zwischen genetischen Faktoren und bestimmten Umwelteinflüssen zurückzuführen. Bei etwa 25% der Menschen entwickeln sich überschießende Immunantworten, die durch harmlose Umweltstoffe wie Pollen oder Nahrungsmittel aber auch Arzneimitte...

Ausführliche Beschreibung

Gespeichert in:
1. Verfasser: Schäfer, Carolin
Beteiligte: Pfützner, W. (Prof. Dr. med.) (BetreuerIn (Doktorarbeit))
Format: Dissertation
Sprache:Deutsch
Veröffentlicht: Philipps-Universität Marburg 2016
Hautkrankheiten
Ausgabe:http://dx.doi.org/10.17192/z2016.0303
Schlagworte:
Online Zugang:PDF-Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

1. http://archiv.ub.uni-marburg.de/diss/z2010/0354


2. Mockenhaupt, M., C. Viboud, et al. (2008). "Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study." J Invest Dermatol 128(1): 35-44.


3. Beeler, A., O. Engler, et al. (2006). "Long-lasting reactivity and high frequency of drug- specific T cells after severe systemic drug hypersensitivity reactions." J Allergy Clin Immunol 117(2): 455-62.


4. Beeler, A. and W. J. Pichler (2006). "In vitro tests of T cell-mediated drug hypersensitivity." Expert Rev Clin Immunol 2(6): 887-900.


5. Pichler, W. J., B. Daubner, et al. "Drug hypersensitivity: flare-up reactions, cross-reactivity and multiple drug hypersensitivity." J Dermatol 38(3): 216-21.


6. Torres, M. J., C. Mayorga, et al. (2009). "Nonimmediate allergic reactions induced by drugs: pathogenesis and diagnostic tests." J Investig Allergol Clin Immunol 19(2): 80-90.


7. Bottema, R. W., M. Kerkhof, et al. "X-chromosome Forkhead Box P3 polymorphisms associ- ate with atopy in girls in three Dutch birth cohorts." Allergy 65(7): 865-74.


8. Meiler, F., S. Klunker, et al. (2008). "Distinct regulation of IgE, IgG4 and IgA by T regulato- ry cells and toll-like receptors." Allergy 63(11): 1455-63.


9. Akdis, C. A. and M. Akdis (2009). "Mechanisms and treatment of allergic disease in the big picture of regulatory T cells." J Allergy Clin Immunol 123(4): 735-46; quiz 747-8.


10. Johansson, S. G., T. Bieber, et al. (2004). "Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003." J Allergy Clin Immunol 113(5): 832-6.


11. Sidoroff, A., S. Halevy, et al. (2001). "Acute generalized exanthematous pustulosis (AGEP)-- a clinical reaction pattern." J Cutan Pathol 28(3): 113-9.


12. Halken, S. (2004). "Prevention of allergic disease in childhood: clinical and epidemiological aspects of primary and secondary allergy prevention." Pediatr Allergy Immunol 15 Suppl 16: 4-5, 9-32.


13. Goldmann, O., S. Lehne, et al. "Age-related susceptibility to Streptococcus pyogenes infec- tion in mice: underlying immune dysfunction and strategy to enhance immunity." J Pathol 220(5): 521-9.


14. Radulovic, S., M. R. Jacobson, et al. (2008). "Grass pollen immunotherapy induces Foxp3- expressing CD4+ CD25+ cells in the nasal mucosa." J Allergy Clin Immunol 121(6): 1467-72, 1472 e1.


15. Gomes, E., M. F. Cardoso, et al. (2004). "Self-reported drug allergy in a general adult Portu- guese population." Clin Exp Allergy 34(10): 1597-601.


16. Pereira-Santos, M. C., A. P. Baptista, et al. (2008). "Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy." Clin Exp Allergy 38(2): 291-7.


17. Aberer, W., A. Bircher, et al. (2003). "Drug provocation testing in the diagnosis of drug hy- persensitivity reactions: general considerations." Allergy 58(9): 854-63.


18. Robinson, D. S., Q. Hamid, et al. (1992). "Predominant TH2-like bronchoalveolar T- lymphocyte population in atopic asthma." N Engl J Med 326(5): 298-304.


19. Huber, B. (2006). "[100 years of allergy: Clemens von Pirquet--his concept of allergy and his basic understanding of the disease: 2: The Pirquet concept of allergy]." Wien Klin Wochenschr 118(23-24): 718-27.


20. Thornton, A. M., C. A. Piccirillo, et al. (2004). "Activation requirements for the induction of CD4+CD25+ T cell suppressor function." Eur J Immunol 34(2): 366-76.


21. Juan, W. H., L. C. Yang, et al. (2004). "Acute generalized exanthematous pustulosis induced by topical lindane." Dermatology 209(3): 239-40.


22. Kidon, M. I. and Y. See (2004). "Adverse drug reactions in Singaporean children." Singapore Med J 45(12): 574-7.


23. Riedl, M. A. and A. M. Casillas (2003). "Adverse drug reactions: types and treatment op- tions." Am Fam Physician 68(9): 1781-90.


24. Jin, C., B. Hantusch, et al. (2008). "Affinity of IgE and IgG against cross-reactive carbohy- drate determinants on plant and insect glycoproteins." J Allergy Clin Immunol 121(1): 185-190 e2.


25. von Mutius, E. (2007). "Allergies, infections and the hygiene hypothesis--the epidemiological evidence." Immunobiology 212(6): 433-9.


26. Kay, A. B. (2001). "Allergy and allergic diseases. First of two parts." N Engl J Med 344(1): 30-7.


27. Ponvert, C., L. Le Clainche, et al. (1999). "Allergy to beta-lactam antibiotics in children." Pediatrics 104(4): e45.


28. Chaabane, A., K. Aouam, et al. (2009). "[Allergy to betalactams: myth and realities]." Med Mal Infect 39(5): 278-87.


29. Khattri, R., T. Cox, et al. (2003). "An essential role for Scurfin in CD4+CD25+ T regulatory cells." Nat Immunol 4(4): 337-42.


30. Lewis, S. A. (2000). "Animals and allergy." Clin Exp Allergy 30(2): 153-7.


31. Szabo, S. J., S. T. Kim, et al. (2000). "A novel transcription factor, T-bet, directs Th1 lineage commitment." Cell 100(6): 655-69.


32. Trautmann, A., K. Kruger, et al. (2005). "Apoptosis and loss of adhesion of bronchial epithe- lial cells in asthma." Int Arch Allergy Immunol 138(2): 142-50.


33. Czerkinsky, C. C., L. A. Nilsson, et al. (1983). "A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells." J Immunol Methods 65(1-2): 109-21.


34. Padilla, A., R. Ferriols, et al. (2007). "[A time series analysis of the cost of the most common drug treatment groups in an intensive care unit]." Farm Hosp 31(5): 307-10.


35. Haddi, E., D. Charpin, et al. (1990). "Atopy and systemic reactions to drugs." Allergy 45(3): 236-9.


36. Riedler, J., W. Eder, et al. (2000). "Austrian children living on a farm have less hay fever, asthma and allergic sensitization." Clin Exp Allergy 30(2): 194-200.


37. Taylor, A. I., H. J. Gould, et al. (2008). "Avian IgY binds to a monocyte receptor with IgG- like kinetics despite an IgE-like structure." J Biol Chem 283(24): 16384-90.


38. Shevach, E. M. (2002). "CD4+ CD25+ suppressor T cells: more questions than answers." Nat Rev Immunol 2(6): 389-400.


39. Carr, T. F. and C. A. Saltoun "Chapter 2: Skin testing in allergy." Allergy Asthma Proc 33 Suppl 1: S6-8.


40. Schaerli, P., M. Britschgi, et al. (2004). "Characterization of human T cells that regulate neutrophilic skin inflammation." J Immunol 173(3): 2151-8.


41. Bastuji-Garin, S., B. Rzany, et al. (1993). "Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme." Arch Dermatol 129(1): 92-6.


42. Nonaka, M., N. Ogihara, et al. (2008). "Combined stimulation of nasal polyp fibroblasts with poly IC, interleukin 4, and tumor necrosis factor alpha potently induces production of thymus-and activation-regulated chemokine." Arch Otolaryngol Head Neck Surg 134(6): 630-5.


43. Hori, S., T. Takahashi, et al. (2003). "Control of autoimmunity by naturally arising regulatory CD4+ T cells." Adv Immunol 81: 331-71.


44. Shevach, E. M., R. S. McHugh, et al. (2001). "Control of T-cell activation by CD4+ CD25+ suppressor T cells." Immunol Rev 182: 58-67.


45. Wing, K., Y. Onishi, et al. (2008). "CTLA-4 control over Foxp3+ regulatory T cell function." Science 322(5899): 271-5.


46. Mayorga, C., M. J. Torres, et al. (2009). "Cutaneous symptoms in drug allergy: what have we learnt?" Curr Opin Allergy Clin Immunol 9(5): 431-6.


47. Enzmann, H. (1980). "[Delayed allergic nasal reactions. (Synonyms: Coombs and Gell's type IV, delayed hypersensitivity, allergy of the tuberculin and eczema type). Studies on the morphology and pathogenesis]." Fortschr Med 98(19): 745-51.


48. Pichler, W. J. (2003). "Delayed drug hypersensitivity reactions." Ann Intern Med 139(8): 683- 93.


49. Moll, I. (2010). "Dermatologie, Thieme Verlag."


50. Rozieres, A., A. Hennino, et al. (2009). "Detection and quantification of drug-specific T cells in penicillin allergy." Allergy 64(4): 534-42.


51. Asero, R. (1998). "Detection of patients with multiple drug allergy syndrome by elective tol- erance tests." Ann Allergy Asthma Immunol 80(2): 185-8.


52. Finotto, S., M. F. Neurath, et al. (2002). "Development of spontaneous airway changes con- sistent with human asthma in mice lacking T-bet." Science 295(5553): 336-8.


53. Seitz, C. S., E. B. Brocker, et al. "Diagnosis of drug hypersensitivity in children and adoles- cents: discrepancy between physician-based assessment and results of testing." Pediatr Allergy Immunol 22(4): 405-10.


54. Pichichero, M. E. and D. M. Pichichero (1998). "Diagnosis of penicillin, amoxicillin, and cephalosporin allergy: reliability of examination assessed by skin testing and oral challenge." J Pediatr 132(1): 137-43.


55. Brunkow, M. E., E. W. Jeffery, et al. (2001). "Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse." Nat Genet 27(1): 68-73.


56. Demoly, P. (2007). "[Drug allergies and drug hypersensitivities]." Rev Prat 57(12): 1326-30.


57. Thong, B. Y., K. P. Leong, et al. (2003). "Drug allergy in a general hospital: Results of a nov- el prospective inpatient reporting system." Ann Allergy Asthma Immunol 90(3): 342- 7.


58. Pichler, W. J., J. Adam, et al. (2011). "Drug hypersensitivity reactions: pathomechanism and clinical symptoms." Med Clin North Am 94(4): 645-64, xv.


59. Shiohara, T., M. Inaoka, et al. (2006). "Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and anti- drug immune responses." Allergol Int 55(1): 1-8.


60. Barbaud, A. (2005). "Drug patch testing in systemic cutaneous drug allergy." Toxicology 209(2): 209-16.


61. Messaad, D., H. Sahla, et al. (2004). "Drug provocation tests in patients with a history sug- gesting an immediate drug hypersensitivity reaction." Ann Intern Med 140(12): 1001- 6.


62. Ajduk, J., I. Marinic, et al. (2008). "Effect of house dust mite immunotherapy on transforming growth factor beta1-producing T cells in asthmatic children." Ann Allergy Asthma Immunol 100(4): 314-22.


63. Leonard, J. P., M. L. Sherman, et al. (1997). "Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production." Blood 90(7): 2541-8.


64. Lindemann, M., J. Bohmer, et al. (2003). "ELISpot: a new tool for the detection of nickel sen- sitization." Clin Exp Allergy 33(7): 992-8.


65. Ando, D. G., J. Clayton, et al. (1989). "Encephalitogenic T cells in the B10.PL model of ex- perimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype." Cell Immunol 124(1): 132-43.


66. Garn, H. and H. Renz (2007). "Epidemiological and immunological evidence for the hygiene hypothesis." Immunobiology 212(6): 441-52.


67. Gomes, E. R. and P. Demoly (2005). "Epidemiology of hypersensitivity drug reactions." Curr Opin Allergy Clin Immunol 5(4): 309-16.


68. Campbell, I. L., T. W. Kay, et al. (1991). "Essential role for interferon-gamma and interleu- kin-6 in autoimmune insulin-dependent diabetes in NOD/Wehi mice." J Clin Invest 87(2): 739-42.


69. Mittmann, N., S. R. Knowles, et al. (2004). "Evaluation of the extent of under-reporting of serious adverse drug reactions: the case of toxic epidermal necrolysis." Drug Saf 27(7): 477-87.


70. Seddiki, N., B. Santner-Nanan, et al. (2006). "Expression of interleukin (IL)-2 and IL-7 recep- tors discriminates between human regulatory and activated T cells." J Exp Med 203(7): 1693-700.


71. Kjellman, N. I. (1987). "Food allergy--treatment and prevention." Ann Allergy 59(5 Pt 2): 168-74.


72. Zheng, Y. and A. Y. Rudensky (2007). "Foxp3 in control of the regulatory T cell lineage." Nat Immunol 8(5): 457-62.


73. Abbas, A. K., K. M. Murphy, et al. (1996). "Functional diversity of helper T lymphocytes." Nature 383(6603): 787-93.


74. Barranco, P. and M. C. Lopez-Serrano (1998). "General and epidemiological aspects of aller- gic drug reactions." Clin Exp Allergy 28 Suppl 4: 61-2.


75. Brockow, K., A. Romano, et al. (2002). "General considerations for skin test procedures in the diagnosis of drug hypersensitivity." Allergy 57(1): 45-51.


76. Mullen, A. C., A. S. Hutchins, et al. (2002). "Hlx is induced by and genetically interacts with T-bet to promote heritable T(H)1 gene induction." Nat Immunol 3(7): 652-8.


77. Ng, W. F., P. J. Duggan, et al. (2001). "Human CD4(+)CD25(+) cells: a naturally occurring population of regulatory T cells." Blood 98(9): 2736-44.


78. Dieckmann, D., C. H. Bruett, et al. (2002). "Human CD4(+)CD25(+) regulatory, contact- dependent T cells induce interleukin 10-producing, contact-independent type 1-like regulatory T cells [corrected]." J Exp Med 196(2): 247-53.


79. Del Prete, G., M. De Carli, et al. (1993). "Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific prolifer- ation and cytokine production." J Immunol 150(2): 353-60.


80. Romagnani, S. (1994). "Human TH1 and TH2 subsets: "eppur si muove"!" Eur Cytokine Netw 5(1): 7-12.


81. Comte, D., S. Petitpierre, et al. "[Hymenoptera venom allergy: new diagnostic tools and man- agement]." Rev Med Suisse 7(291): 844-9.


82. Niggemann, B. "IgE-mediated latex allergy--an exciting and instructive piece of allergy histo- ry." Pediatr Allergy Immunol 21(7): 997-1001.


83. Jutel, M., M. Akdis, et al. (2003). "IL-10 and TGF-beta cooperate in the regulatory T cell re- sponse to mucosal allergens in normal immunity and specific immunotherapy." Eur J Immunol 33(5): 1205-14.


84. Wills-Karp, M. (2001). "IL-12/IL-13 axis in allergic asthma." J Allergy Clin Immunol 107(1): 9-18.


85. Blease, K., C. Jakubzick, et al. (2001). "IL-13 fusion cytotoxin ameliorates chronic fungal- induced allergic airway disease in mice." J Immunol 167(11): 6583-92.


86. Korn, T., E. Bettelli, et al. (2009). "IL-17 and Th17 Cells." Annu Rev Immunol 27: 485-517.


87. Dabbagh, K., K. Takeyama, et al. (1999). "IL-4 induces mucin gene expression and goblet cell metaplasia in vitro and in vivo." J Immunol 162(10): 6233-7.


88. Gomez, M. B., M. J. Torres, et al. (2004). "Immediate allergic reactions to betalactams: facts and controversies." Curr Opin Allergy Clin Immunol 4(4): 261-6.


89. Torgerson, T. R. and H. D. Ochs (2007). "Immune dysregulation, polyendocrinopathy, enteropathy, X-linked: forkhead box protein 3 mutations and lack of regulatory T cells." J Allergy Clin Immunol 120(4): 744-50; quiz 751-2.


90. Gomez, E., M. J. Torres, et al. "Immunologic evaluation of drug allergy." Allergy Asthma Immunol Res 4(5): 251-63.


91. Sakaguchi, S., N. Sakaguchi, et al. (1995). "Immunologic self-tolerance maintained by acti- vated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases." J Immunol 155(3): 1151-64.


92. Huang, H. and W. E. Paul (1998). "Impaired interleukin 4 signaling in T helper type 1 cells." J Exp Med 187(8): 1305-13.


93. Romagnani, S., E. Maggi, et al. (1991). "Increased numbers of Th2-like CD4+ T cells in tar- get organs and in the allergen-specific repertoire of allergic patients. Possible role of IL-4 produced by non-T cells." Int Arch Allergy Appl Immunol 94(1-4): 133-6.


94. Smart, J. M. and A. S. Kemp (2002). "Increased Th1 and Th2 allergen-induced cytokine re- sponses in children with atopic disease." Clin Exp Allergy 32(5): 796-802.


95. Bettelli, E., T. Korn, et al. (2008). "Induction and effector functions of T(H)17 cells." Nature 453(7198): 1051-7.


96. Gabrielsson, S., A. Soderlund, et al. (2001). "Influence of atopic heredity on IL-4-, IL-12-and IFN-gamma-producing cells in in vitro activated cord blood mononuclear cells." Clin Exp Immunol 126(3): 390-6.


97. Meves, A. (2006). "Intensivkurs Dermatolgie.Elsevier / Urban & Fischer Verlag."


98. Roncarolo, M. G., S. Gregori, et al. (2006). "Interleukin-10-secreting type 1 regulatory T cells in rodents and humans." Immunol Rev 212: 28-50.


99. Wills-Karp, M., J. Luyimbazi, et al. (1998). "Interleukin-13: central mediator of allergic asthma." Science 282(5397): 2258-61.


100. Pochard, P., P. Gosset, et al. (2002). "Lactic acid bacteria inhibit TH2 cytokine production by mononuclear cells from allergic patients." J Allergy Clin Immunol 110(4): 617-23.


101. Howard, T. D., D. A. Meyers, et al. (2000). "Mapping susceptibility genes for asthma and allergy." J Allergy Clin Immunol 105(2 Pt 2): S477-81.


102. von Boehmer, H. (2005). "Mechanisms of suppression by suppressor T cells." Nat Immunol 6(4): 338-44.


103. Mayorga, C., R. R. Pena, et al. (2006). "Monitoring the acute phase response in non- immediate allergic drug reactions." Curr Opin Allergy Clin Immunol 6(4): 249-57.


104. Jäger, L. W., B.;Ballmer-Weber,B.;Vieths,S. (2000). "Nahrungsmittelallergien und - intoleranzen: Immunologie -Diagnostik -Therapie -Prophylaxe. Urban & Fischer Verlag, Stuttgart."


105. Curotto de Lafaille, M. A. and J. J. Lafaille (2009). "Natural and adaptive foxp3+ regulatory T cells: more of the same or a division of labor?" Immunity 30(5): 626-35.


106. Sakaguchi, S. (2004). "Naturally arising CD4+ regulatory t cells for immunologic self- tolerance and negative control of immune responses." Annu Rev Immunol 22: 531-62.


107. Sakaguchi, S. (2005). "Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self." Nat Immunol 6(4): 345-52.


108. Terrados, S., M. Blanca, et al. (1995). "Nonimmediate reactions to betalactams: prevalence and role of the different penicillins." Allergy 50(7): 563-7.


109. WHO (1966). "Organisation W H International drug monitoring."


110. Wantke, F. and S. Wöhrl (2008). "Penicillinallergie." 10-13.


111. Cetinkaya, F. and Y. Cag (2004). "Penicillin sensitivity among children without a positive history for penicillin allergy." Pediatr Allergy Immunol 15(3): 278-80.


112. Ruby, P., F. Collette, et al. (2009). "Perspective taking to assess self-personality: what's modi- fied in Alzheimer's disease?" Neurobiol Aging 30(10): 1637-51.


113. Majkowska-Wojciechowska, B., J. Pelka, et al. (2007). "Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children." Allergy 62(9): 1044-50.


114. Bettelli, E., Y. Carrier, et al. (2006). "Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells." Nature 441(7090): 235-8.


115. Renzi, P. M., J. P. Turgeon, et al. (1999). "Reduced interferon-gamma production in infants with bronchiolitis and asthma." Am J Respir Crit Care Med 159(5 Pt 1): 1417-22.


116. Bonnefoy, J. Y., J. F. Gauchat, et al. (1996). "Regulation of human IgE synthesis." Ann N Y Acad Sci 796: 59-71.


117. Chen, Y., V. K. Kuchroo, et al. (1994). "Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis." Science 265(5176): 1237-40.


118. Beissert, S., A. Schwarz, et al. (2006). "Regulatory T cells." J Invest Dermatol 126(1): 15-24.


119. Ziegler, S. F. (2008). "Regulatory T cells and inflammation: better late than never." Immunity 29(1): 5-7.


120. Peterson, R. A. "Regulatory T-cells: diverse phenotypes integral to immune homeostasis and suppression." Toxicol Pathol 40(2): 186-204.


121. Humrich, J. and G. Riemekasten (2006). "[Regulatory T cells in rheumatic diseases]." Dtsch Med Wochenschr 131(41): 2288-91.


122. Romagnani, S. (2006). "Regulatory T cells: which role in the pathogenesis and treatment of allergic disorders?" Allergy 61(1): 3-14.


123. Aktories, K. F., U;Hofmann,F.B.;Starke,K. (2009). "Repititorium Allgemeine und spezielle Pharmakologie und Toxikologie, Urban & Fischer Verlag, München."


124. Pamphilon, D. H. and M. L. Scott (2007). "Robin Coombs: his life and contribution to haema- tology and transfusion medicine." Br J Haematol 137(5): 401-8.


125. Hazlett, L. D., X. L. Rudner, et al. (2002). "Role of IL-12 and IFN-gamma in Pseudomonas aeruginosa corneal infection." Invest Ophthalmol Vis Sci 43(2): 419-24.


126. Rozieres, A., M. Vocanson, et al. (2009). "Role of T cells in nonimmediate allergic drug reac- tions." Curr Opin Allergy Clin Immunol 9(4): 305-10.


127. Palomares, O., G. Yaman, et al. (2010). "Role of Treg in immune regulation of allergic dis- eases." Eur J Immunol 40(5): 1232-40.


128. Schulz, E. G., L. Mariani, et al. (2009). "Sequential polarization and imprinting of type 1 T helper lymphocytes by interferon-gamma and interleukin-12." Immunity 30(5): 673- 83.


129. Carr, T. F. and C. A. Saltoun (2012). "Chapter 2: Skin testing in allergy." Allergy Asthma Proc 33 Suppl 1: S6-8.


130. Grindebacke, H., P. Larsson, et al. (2009). "Specific immunotherapy to birch allergen does not enhance suppression of Th2 cells by CD4(+)CD25(+) regulatory T cells during pollen season." J Clin Immunol 29(6): 752-60.


131. Bircher, A. (2007). " Stellenwert des Lymphozytentransformationstests in der Diagnostik der Arzneimittelallergie." Allergo Journal 2007.


132. Borchers, A. T., J. L. Lee, et al. (2008). "Stevens-Johnson syndrome and toxic epidermal necrolysis." Autoimmun Rev 7(8): 598-605.


133. Bohle, B., T. Kinaciyan, et al. (2007). "Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation." J Allergy Clin Immunol 120(3): 707-13.


134. Neumann-Haefelin, C., H. C. Spangenberg, et al. (2004). "[Suppressor T-cells: immunologic regulator cells and clinical perspectives]." Dtsch Med Wochenschr 129(30): 1627-30.


135. Dow, S. W., J. Schwarze, et al. (1999). "Systemic and local interferon gamma gene delivery to the lungs for treatment of allergen-induced airway hyperresponsiveness in mice." Hum Gene Ther 10(12): 1905-14.


136. Afkarian, M., J. R. Sedy, et al. (2002). "T-bet is a STAT1-induced regulator of IL-12R ex- pression in naive CD4+ T cells." Nat Immunol 3(6): 549-57.


137. Munthe-Kaas, M. C., K. H. Carlsen, et al. (2008). "T cell-specific T-box transcription factor haplotype is associated with allergic asthma in children." J Allergy Clin Immunol 121(1): 51-6.


138. Klimek, L. and I. Bottcher (2008). "[T-cells regulate the immune-response in allergic rhini- tis]." Laryngorhinootologie 87(10): 733-43.


139. Mosmann, T. R. and R. L. Coffman (1989). "TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties." Annu Rev Immunol 7: 145-73.


140. Mashishi, T. and C. M. Gray (2002). "The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes." Clin Chem Lab Med 40(9): 903-10.


141. Uter, W., J. Hegewald, et al. (2005). "The European standard series in 9 European countries, 2002/2003 --first results of the European Surveillance System on Contact Allergies." Contact Dermatitis 53(3): 136-45.


142. Fujio, K., T. Okamura, et al. "The Family of IL-10-secreting CD4+ T cells." Adv Immunol 105: 99-130.


143. Rajan, T. V. (2003). "The Gell-Coombs classification of hypersensitivity reactions: a re- interpretation." Trends Immunol 24(7): 376-9.


144. Nelms, K., A. D. Keegan, et al. (1999). "The IL-4 receptor: signaling mechanisms and biolog- ic functions." Annu Rev Immunol 17: 701-38.


145. Collison, L. W., C. J. Workman, et al. (2007). "The inhibitory cytokine IL-35 contributes to regulatory T-cell function." Nature 450(7169): 566-9.


146. Murphy, K. M. and S. L. Reiner (2002). "The lineage decisions of helper T cells." Nat Rev Immunol 2(12): 933-44.


147. Cohn, L., R. J. Homer, et al. (1999). "T helper 1 cells and interferon gamma regulate allergic airway inflammation and mucus production." J Exp Med 190(9): 1309-18.


148. Pichler, W. J. and J. Tilch (2004). "The lymphocyte transformation test in the diagnosis of drug hypersensitivity." Allergy 59(8): 809-20.


149. Viinanen, A., S. Munhbayarlah, et al. (2007). "The protective effect of rural living against atopy in Mongolia." Allergy 62(3): 272-80.


150. Saint-Mezard, P., F. Berard, et al. (2004). "The role of CD4+ and CD8+ T cells in contact hypersensitivity and allergic contact dermatitis." Eur J Dermatol 14(3): 131-8.


151. Oppenheim, J. and H. Fujiwara (1996). "The role of cytokines in cancer." Cytokine Growth Factor Rev 7(3): 279-88.


152. Girolomoni, G. and S. Pastore (2001). "The role of keratinocytes in the pathogenesis of atopic dermatitis." J Am Acad Dermatol 45(1 Suppl): S25-8.


153. Iwakura, Y., S. Nakae, et al. (2008). "The roles of IL-17A in inflammatory immune responses and host defense against pathogens." Immunol Rev 226: 57-79.


154. Kirchner, D. B. (2002). "The spectrum of allergic disease in the chemical industry." Int Arch Occup Environ Health 75 Suppl: S107-12.


155. Lammintausta, K. and O. Kortekangas-Savolainen (2005). "The usefulness of skin tests to prove drug hypersensitivity." Br J Dermatol 152(5): 968-74.


156. Polansky, J. K. and J. Huehn (2007). "[To be or not to be a Treg: epigenetic regulation of Foxp3 expression in regulatory T cells]." Z Rheumatol 66(5): 417-20.


157. French, L. E. (2006). "Toxic epidermal necrolysis and Stevens Johnson syndrome: our current understanding." Allergol Int 55(1): 9-16.


158. Mangan, P. R., L. E. Harrington, et al. (2006). "Transforming growth factor-beta induces de- velopment of the T(H)17 lineage." Nature 441(7090): 231-4.


159. Mosmann, T. R., H. Cherwinski, et al. (2005). "Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. 1986." J Immunol 175(1): 5-14.


160. Romagnani, S. (1991). "Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease." Int J Clin Lab Res 21(2): 152-8.


161. Backstrom, M., T. Mjorndal, et al. (2004). "Under-reporting of serious adverse drug reactions in Sweden." Pharmacoepidemiol Drug Saf 13(7): 483-7.


162. Halevy, S. (2009). "Acute generalized exanthematous pustulosis." Curr Opin Allergy Clin Immunol 9(4): 322-8.


163. Kramer, U., J. Heinrich, et al. (1999). "Age of entry to day nursery and allergy in later child- hood." Lancet 353(9151): 450-4.


164. Forster, R., A. Schubel, et al. (1999). "CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs." Cell 99(1): 23-33.


165. Pichler, W. J., N. Yawalkar, et al. (2002). "Cellular and molecular pathophysiology of cuta- neous drug reactions." Am J Clin Dermatol 3(4): 229-38.


166. Daubner, B., M. Groux-Keller, et al. (2012). "Multiple drug hypersensitivity: normal Treg cell function but enhanced in vivo activation of drug-specific T cells." Allergy 67(1): 58- 66.


167. Strachan, D. P. (1989). "Hay fever, hygiene, and household size." Bmj 299(6710): 1259-60.


168. Hebenstreit, D., P. Luft, et al. (2003). "IL-4 and IL-13 induce SOCS-1 gene expression in A549 cells by three functional STAT6-binding motifs located upstream of the tran- scription initiation site." J Immunol 171(11): 5901-7.


169. Wolfgang Pfützner, Carolin Intrup, Christian Möbs Predominance of IL-5-secreting drug-specific T cells in subgroups of patients with drug-induced delayed-type hypersensitivity reaction. 2014; -Drug Hypersensitivity Meeting (DHM), Bern Switzerland


170. Black, C. A. (1999). "Delayed type hypersensitivity: current theories with an historic perspec- tive." Dermatol Online J 5(1): 7.


171. Pekkarinen, P. T., L. von Hertzen, et al. (2007). "A disparity in the association of asthma, rhinitis, and eczema with allergen-specific IgE between Finnish and Russian Karelia." Allergy 62(3): 281-7.


172. Basketter, D. A., G. F. Gerberick, et al. (1998). "Strategies for identifying false positive re- sponses in predictive skin sensitization tests." Food Chem Toxicol 36(4): 327-33.


173. Davies, D. M., C. H. Ashton, et al. (1977). "Comprehensive clinical drug information service: first year's experience." Br Med J 1(6053): 89-90.


174. Platts-Mills, T. A., J. W. Vaughan, et al. (2001). "Decreased prevalence of asthma among children with high exposure to cat allergen: relevance of the modified Th2 response." Mediators Inflamm 10(6): 288-91.


175. Wong, C. K., C. Y. Ho, et al. (2001). "Proinflammatory cytokines (IL-17, IL-6, IL-18 and IL- 12) and Th cytokines (IFN-gamma, IL-4, IL-10 and IL-13) in patients with allergic asthma." Clin Exp Immunol 125(2): 177-83.


176. Ilona J. Frieden, M. D. a. L. F. E., M.D. (2011). "Pediatric dermatology." ISI Journal Citation Reports © Ranking: 2011: 40/58 (Dermatology); 76/115 (Pediatrics)


177. Liu, W., A. L. Putnam, et al. (2006). "CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells." J Exp Med 203(7): 1701-11.


178. Hirai, K., M. Yamaguchi, et al. (1990). "Enhancement of human basophil histamine release by interleukin 5." J Exp Med 172(5): 1525-8.


179. Iwamoto, I., H. Nakajima, et al. (1993). "Interferon gamma regulates antigen-induced eosino- phil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells." J Exp Med 177(2): 573-6.


180. Akdis, M., J. Verhagen, et al. (2004). "Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells." J Exp Med 199(11): 1567-75.


181. Sakaguchi, S. (2003). "The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery." J Clin Invest 112(9): 1310-2.


182. Gri, G., S. Piconese, et al. (2008). "CD4+CD25+ regulatory T cells suppress mast cell degranulation and allergic responses through OX40-OX40L interaction." Immunity 29(5): 771-81.


183. Korn, T., M. Oukka, et al. (2007). "Th17 cells: effector T cells with inflammatory properties." Semin Immunol 19(6): 362-71.


184. Nikolich-Zugich, J. and B. D. Rudd "Immune memory and aging: an infinite or finite re- source?" Curr Opin Immunol 22(4): 535-40.


185. Gundel, R. H., L. G. Letts, et al. (1991). "Human eosinophil major basic protein induces air- way constriction and airway hyperresponsiveness in primates." J Clin Invest 87(4): 1470-3.


186. Buckner, J. H. "Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases." Nat Rev Immunol 10(12): 849-59.


187. Ding, Y., J. Xu, et al. (2012). "Regulatory T cell migration during an immune response." Trends Immunol 33(4): 174-80.


188. Yoshihisa, Y. and T. Shimizu "Metal allergy and systemic contact dermatitis: an overview." Dermatol Res Pract 2012: 749561.


189. Smith, R. J. and G. Aston-Jones (2008). "Noradrenergic transmission in the extended amyg- dala: role in increased drug-seeking and relapse during protracted drug abstinence." Brain Struct Funct 213(1-2): 43-61.


190. Trautmann, A., M. Akdis, et al. (2000). "T cell-mediated Fas-induced keratinocyte apoptosis plays a key pathogenetic role in eczematous dermatitis." J Clin Invest 106(1): 25-35.


191. Akkoc, T., P. J. de Koning, et al. (2008). "Increased activation-induced cell death of high IFN-gamma-producing T(H)1 cells as a mechanism of T(H)2 predominance in atopic diseases." J Allergy Clin Immunol 121(3): 652-658 e1.


192. Altmeyer, M., M. Barthel, et al. "Absence of poly(ADP-ribose) polymerase 1 delays the onset of Salmonella enterica serovar Typhimurium-induced gut inflammation." Infect Immun 78(8): 3420-31.


193. Akkoc, T., M. Akdis, et al. "Update in the mechanisms of allergen-specific immunotheraphy." Allergy Asthma Immunol Res 3(1): 11-20.


194. Stock, P., C. Rolinck-Werninghaus, et al. (2007). "The role of anti-IgE therapy in combina- tion with allergen specific immunotherapy for seasonal allergic rhinitis." BioDrugs 21(6): 403-10.


195. Cruse, H., C. Bartling, et al. (1995). "A modular artificial neural net for controlling a six- legged walking system." Biol Cybern 72(5): 421-30.